Connection
Alan Palestine to Antineoplastic Agents
This is a "connection" page, showing publications Alan Palestine has written about Antineoplastic Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.403 |
|
|
|
-
Mackin AG, Pecen PE, Dinsmore AL, Patnaik JL, Gonzalez R, Robinson WA, Palestine AG. Inflammatory side effects of BRAF and MEK inhibitors. Melanoma Res. 2019 10; 29(5):522-526.
Score: 0.317
-
Edwards RG, Vanderhoof S, Palestine A, Seibold LK. Bilateral Secondary Angle Closure During Daratumumab Infusion: A Case Report and Review of the Literature. J Glaucoma. 2020 08; 29(8):e83-e86.
Score: 0.084
-
Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983 Sep; 96(3):275-82.
Score: 0.002